Thermo Fisher Scientific

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TMO and other ETFs, options, and stocks.

About TMO

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

CEO

Marc N. Casper

CEOMarc N. Casper

Employees

122,000

Employees122,000

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

1960

Founded1960

Employees

122,000

Employees122,000

TMO Key Statistics

Market cap

231.79B

Market cap231.79B

Price-Earnings ratio

36.88

Price-Earnings ratio36.88

Dividend yield

0.25%

Dividend yield0.25%

Average volume

1.94M

Average volume1.94M

High today

$614.64

High today$614.64

Low today

$599.30

Low today$599.30

Open price

$600.54

Open price$600.54

Volume

2.71M

Volume2.71M

52 Week high

$614.65

52 Week high$614.65

52 Week low

$415.60

52 Week low$415.60

TMO News

Simply Wall St 19h

Thermo Fisher Scientific Second Quarter 2024 Earnings: EPS Beats Expectations

Thermo Fisher Scientific ( ) Second Quarter 2024 Results Key Financial Results Revenue: US$10.5b (down 1.4% from 2Q 2023). Net income: US$1.55b (up 14% from...

Reuters 2d

Q2 2024 Thermo Fisher Scientific Inc Earnings Call

Participants Rafael Tejada; Vice President - Investor Relations; Thermo Fisher Scientific Inc Marc Casper; Chairman of the Board, President, Chief Executive O...

Benzinga 3d

Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted a second-quarter revenue of $10.54 billion, down 1% year-over-year, beating the consensus of $10....

Analyst ratings

75%

of 28 ratings

Buy

75%

Hold

25%

Sell

More TMO News

Reuters 3d

Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement

(Reuters) - Thermo Fisher on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for...

Seeking Alpha 3d

Thermo Fisher posts Q2 beat thanks to instruments segment

Thermo Fisher Scientific (NYSE:TMO) reported better-than-expected Q2 2024 financials on Wednesday as the healthcare giant’s Analytical Instruments segment expan...